Zevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of DirectorsGlobeNewsWire • 03/30/23
Zevra Therapeutics Announces Collaboration with RARE-X and the Sleep Consortium as Founding Member of New Sleep Data InitiativeGlobeNewsWire • 03/17/23
Zevra Therapeutics Files Definitive Proxy Statement and Mails Letter to ShareholdersGlobeNewsWire • 03/15/23
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate UpdatesGlobeNewsWire • 03/07/23